Diet-induced protection against lipopolysaccharide includes increased hepatic NO production

Journal of Surgical Research

Volumn 82, Issue 2, 1999, Pages 339-345

  Harris, Hobart W ^a   Rockey, Don C ^b   Young, David M ^a   Welch, William J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

Endothelial cells; Endotoxin; Hypertriglyceridemia; Lipoproteins; Liver; Sepsis; Very low density lipoprotein

Indexed keywords

FRUCTOSE; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET; ENDOTOXEMIA; FEEDING; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA; HYPERTRIGLYCERIDEMIA; LETHALITY; MALE; MORTALITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SEPSIS;

EID: 0032866189     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5570     Document Type: Article

References (44)

1. Beisel W. R. Metabolic response to infection. Annu. Rev. Med. 26:1975;9.
2. Pekala P. H., Kawakami M., Angus C. W., Lane M. D., Cerami A. Selective inhibition of synthesis of enzymes for de novo fatty acid biosynthesis by an endotoxin-induced mediator from exudate cells. Proc. Natl. Acad. Sci. USA. 80:1983;2743.
3. Patton J. S., Shepard H. M., Wilking H., Lewis G., Aggarwal B. B., Eessalu T. E., Gavin L. A. Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. Proc. Natl. Acad. Sci. USA. 83:1986;8313.
4. Chajek-Shaul T., Friedman G., Stein O., Shiloni E., Etienne J., Stein Y. Mechanism of the hyperlipidemia induced by tumor necrosis factor administration to rats. Biochim. Biophys. Acta. 1001:1989;316.
5. Feingold K. R., Serio M. K., Adi S., Moser A. H., Grunfeld C. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology. 124:1989;2336.
6. Grunfeld C., Ade S., Soued M., Moser A., Fiers W., Feingold K. R. Search for mediators of the lipogenic effects of tumor necrosis factor: Potential role for interleukin 6. Cancer Res. 50:1990;4233.
7. Harris H. W., Grunfeld C., Feingold K. R., Read T. E., Kane J. P., Jones A. L., Eichbaum E. B. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J. Clin. Invest. 91:1993;1028.
8. Read T. E., Harris H. W., Grunfeld C., Feingold K. R., Calhoun M. C., Kane J. P., Rapp J. H. Chylomicrons enhance endotoxin excretion in bile. Infect. Immunity. 61:1993;3496.
9. Read T., Grunfeld C., Kumwenda Z., Calhoun M., Kane J., Feingold K., Rapp J. Triglyceride-rich lipoproteins prevent septic death in rats. J. Exp. Med. 182:1995;267.
10. Harris H., Rockey D., Chau P., Kane J., Rapp J. Effect of chylomicrons on the clearance of endotoxin by hepatocytes. Surg. Forum. 47:1996;10.
11. Harris H., Chau P., Kane J., Rapp J. Endogenous hypertriglyceridemia protects against endotoxemia in rats. J. Endotoxin Res. 3:1996;26.
12. Harris H. W., Grunfeld C., Feingold K. R., Rapp J. H. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J. Clin. Invest. 86:1990;696.
13. Harris H., Rockey D., Chau P. Chylomicrons alter hepatic distribution and cellular response to endotoxin. Hepatology. 27:1998;1341.
14. Ghermay A. P., Brady S., Havel R. J., Harris H. W., Rapp J. H. Sepsis increases endocytosis of endotoxin into hepatocytes. Surgery. 120:1996;393.
15. Westphal V. O., Lüderitz O., Bister F. Über die extraktion von bakterien mit phenol/wasser. Z. Naturforsch. B. 7:1952;148.
16. Harris H. W., Eichbaum E. B., Kane J. P., Rapp J. H. Detection of endotoxin in triglyceride-rich lipoproteins in vitro. J. Lab. Clin. Med. 118:1991;186.
17. Eichbaum E. B., Harris H. W., Kane J. P., Rapp J. H. Chylomicrons can inhibit endotoxin activity in vitro. J. Surg. Res. 1991;51.
18. Bissell D., Tilles J. Morphology and function of cells of human embryonic liver in monolayer culture. J. Cell Biol. 50:1971;222.
19. Knook D., Sleyster E. Isolated parenchymal, Kupffer and endothelial rat liver cells characterized by their lysosomal enzyme content. Biochem. Biophys. Res. Commun. 96:1980;250.
20. Pitas R., Innerarity T., Weinstein J., Mahley R. Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Arteriosclerosis. 1:1981;177.
21. Irving M. G., Roll F. J., Huang S., Bissell D. M. Characterization and culture of sinusoidal endothelium from normal rat liver: Lipoprotein uptake and collagen phenotype. Gastroenterology. 87:1984;1233.
22. Rockey D., Chung J. Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility. J. Clin. Invest. 95:1995;1199.
23. Melton D. A., Krieg P. A., Rebagliati M. R., Maniatis T., Zinn K., Green M. R. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12:1984;7035.
24. Jarnagin W. R., Rockey D. C., Koteliansky V. E., Wang S. S., Bissell D. M. Expression of variant fibronectins in wound healing: Cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J. Cell Biol. 127:1994;2037.
25. 15. Anal. Biochem. 126:1982;131.
26. Verschoor L., Chen Y.-D. I., Reaven E. P., Reaven G. M. Glucose and fructose feeding lead to alterations in structure and function of very low density lipoproteins. Horm. Metab. Res. 17:1985;285.
27. Nussler A. K., Di Silvio M., Billiar T. R., Hoffman R. A., Geller D. A., Selby R., Madariaga J. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J. Exp. Med. 176:1992;261.
28. Geller D. A., Nussler A. K., Di Silvio M., Lowenstein C. J., Shapiro R. A., Wang S. C., Simmons R. L. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl. Acad. Sci. USA. 90:1993;522.
29. Spitzer J. A. Cytokine stimulation of nitric oxide formation and differential regulation in hepatocytes and nonparenchymal cells of endotoxemic rats. Hepatology. 19:1994;217.
30. Geller D. A., de Vera M. E., Russell D. A., Shapiro R. A., Nussler A. K., Simmons R. L., Billiar T. R. A central role for IL-1 beta in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase: IL-1 beta induces hepatic nitric oxide synthesis. J. Immunol. 155:1995;4890.
31. Griffiths M., Messent M., MacAllister R., Evans T. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol. 110:1993;963.
32. Gl. Biochem. Biophys. Res. Commun. 199:1994;147.
33. László F., Whittle B., Evans S., Moncada S. Association of microvascular leakage with induction of nitric oxide synthase: Effects of nitric oxide synthase inhibitors in various organs. Eur. J. Pharmacol. 283:1995;47.
34. Tracey W., Tse J., Carter G. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: Pharmacological evaluation of nitric oxide synthase inhibitors. J. Pharmacol. Exp. Ther. 272:1995;1011.
35. Wu C., Ruetten H., Thiermermann C. Comparison of the effects of aminoguanidine andNl. Eur. J. Pharmacol. 300:1996;99.
36. Takano H., Yoshikawa T., Yamaguchi T., Hongo H., Fujii T., Boku Y., Yoshida N. Effects of aminoguanidine on systemic inflammatory response syndrome induced by platelet activating factor and by lipopolysaccharide in rats. Eur. J. Pharmacol. 323:1997;107.
37. Hock C., Yin K., Yue G., Wong P. Effects of inhibition of nitric oxide synthase by aminoguanidine in acute endotoxemia. Am. J. Physiol. 272:1997;H843.
38. Unno N., Wang H., Menconi M., Tytgat S., Larkin V., Smith M., Morin M. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology. 113:1997;1246.
39. Wu C., Chen S., Szabo C., Thiemermann C., Vane J. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br. J. Pharmacol. 114:1995;1666.
40. Mulder M., Van Lambalgen A., Huisman E., Visser J., Van Den Bos G., Thijs L. Protective role of NO in the regional hemodynamic changes during acute endotoxemia in rats. Am. J. Physiol. 266:1994;H1558.
41. Kobayashi H., Nonami T., Kurokawa T., Takeuchi Y., Harada A., Nakao A., Takagi H. Role of endogenous nitric oxide in ishcemia-reperfusion injury in rat liver. J. Surg. Res. 59:1995;772.
42. Huang T., Nishida T., Kamike W., Kosaka H., Seiyama A., Morimoto Y., Tanaka S. Role of nitric oxide in oxygen transport in rat liver sinusoids during endotoxemia. Hepatology. 26:1997;336.
43. Kim Y., deVera M., Watkins S., Billiar T. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-α-induced apoptosis by inducing heat shock protein 70 expression. J. Biol. Chem. 272:1997;1402.
44. Rodeberg D., Chaet M., Bass R., Arkovitz M., Garcia V. Nitric oxide: An overview. Am. J. Surg. 170:1995;292.